Status:
UNKNOWN
Chewing Clopidogrel in Addition to Regular Oral Clopidogrel Treatment to Improve Platelets Aggregation in Patient With NON ST ELEVATION MI
Lead Sponsor:
Sheba Medical Center
Conditions:
Platlet Aggregation
Major Bleeding Outcomes
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Since the absorption of clopidogrel through the gastrointestinal tract is limited, we want to examine whether adding clopidogrel by chewing will overcome the limited gastrointestinal absorption, and h...
Eligibility Criteria
Inclusion
- Male and Female older than 18 years old with non-ST myocardial infarction
Exclusion
- Current treatment with anticoagulation medication, any type of cerebro vascular event in the past, active bleeding, active peptic ulcer disease, pregnant women, any inability to sign an informed consent of participate in the study
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00889044
Start Date
April 1 2009
End Date
June 1 2011
Last Update
April 28 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center, Cardiac Institute
Tel Litwinsky, Tel Hashomer, Israel
2
Sheba_medical_center
Ramat Gan, Israel